Presciption for Success: Bridging Regulation and Innovation in Medicine

The United States has always led the charge in the discovery and delivery of innovative pharmaceuticals and medical therapies.  To keep that edge, stakeholders must constantly evaluate all aspects of the health care delivery system- from clinical trials to medical innovation to benefits plans.

Join Bloomberg Government analysts along with industry and government experts as we discuss how regulatory, medical and insurance sectors can work together to improve the delivery of modern health care.

Key topics will include:

• How agencies like the FDA can protect patients while supporting advancements in treatments, drugs and therapies
• How both medical and regulatory communities can work in their respective spheres to mitigate barriers to medical and pharmaceutical innovations
• The challenges and opportunities that precision medicine is bringing to patients, insurers and regulators

Underwritten by: